Skip to content
NBlaz – Lifestyle
Author:
Resalis Therapeutics SRL
Resalis Announces Initiation of Phase 1b Clinical Study Evaluating RES-010 as Treatment to Address Unmet Needs in Obesity
June 29, 2026